Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares Outstanding
Ratios

Immunocore Holdings (IMCR) Cost of Revenue (2023 - 2025)

Immunocore Holdings (IMCR) has disclosed Cost of Revenue for 3 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 719.09% to $2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Dec 2025, up 86.27% year-over-year, with the annual reading at $5.1 million for FY2025, 86.27% up from the prior year.
  • Cost of Revenue hit $2.7 million in Q4 2025 for Immunocore Holdings, up from $513000.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $2.7 million in Q4 2025 to a low of $200000.0 in Q4 2023.
  • Historically, Cost of Revenue has averaged $738000.0 across 3 years, with a median of $397000.0 in 2023.
  • Biggest YoY gain for Cost of Revenue was 719.09% in 2025; the steepest drop was 39.07% in 2025.
  • Year by year, Cost of Revenue stood at $200000.0 in 2023, then soared by 65.0% to $330000.0 in 2024, then soared by 719.09% to $2.7 million in 2025.
  • Business Quant data shows Cost of Revenue for IMCR at $2.7 million in Q4 2025, $513000.0 in Q3 2025, and $1.0 million in Q2 2025.